What to watch with Skincare DNA and menopause?

Combining skincare DNA tests with menopause is an area where marketing often outpaces evidence. While there are plausible biological links—such as the COMT rs4680 variant affecting estrogen and catecholamine metabolism, which could theoretically influence skin aging and stress responses during menopause—direct clinical proof is lacking. MTHFR variants are also sometimes mentioned, but blood homocysteine levels are the relevant clinical marker, not genotype alone. No robust human studies demonstrate that such genetic insights lead to better skincare outcomes in menopause. Most direct-to-consumer tests overstate their predictive power. A more evidence-based approach focuses on proven interventions: moisturizing, collagen support, sun protection, and, if appropriate, hormone replacement therapy under medical guidance. DNA results may serve as a conversation starter but should not drive expensive or risky treatments. Be cautious of products claiming to be 'personalized' solely based on gene variants—skin response is multifactorial.